J&J | JNJ - Loan Capital


J&J reported $37.34B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
AbbVie USD 64.53B 5.59B Mar/2026
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 51.86B 27M Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Biogen USD 7.29B 1B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
CONMED USD 657.05M 203.11M Jun/2026
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Medtronic USD 27.88B 255M Dec/2025
Merck USD 51.08B 4.41B Jun/2026
Merit Medical Systems USD 736.26M 1.1M Jun/2026
Novartis USD 37.49B 42M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teva Pharmaceutical Industries USD 12.09B 1.92B Jun/2026
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026
Zoetis USD 9.05B 3M Jun/2026